TechAnalyzer Proכל המניות רשימות השבוע בשוק מדדים נושאיים
עבריתEnglishРусскийالعربيةFrançaisEspañolDeutschPortuguêsItalianoУкраїнська

CVS Health Corp CVS

Stock research in plain language · As of Oct 04, 2026 · updated once a week, after the trading week closes

What the company does

CVS Health Corp is a large-cap company in the Healthcare sector (Healthcare Plans), with a market value of $110.6B, based in the USA.

It employs about 219,000 people and has been listed since Dec 17, 1984.

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Cheap or expensive? priced in line with its group

Its price-to-earnings (P/E) is 22.5 versus 20.2 for 4 direct peers — priced in line with its group.

Revenue is growing 7% versus the same quarter last year.

On analysts' next-year forecasts the multiple drops to 10.7 — they expect higher earnings.

The average analyst price target is 116.28, 34% above the current price (their view, not ours).

The stock sits at 43% of its one-year range (0% = the low, 100% = the high).

The risks

Strengths

What changed this week

Over the past week the stock fell 3.0% (for comparison: S&P 500 -0.2%, sector ETF XLV -2.6%).

This week's news

Daily technical analysis of CVS Health Corp